GABAA α5 subunit-containing receptors do not contribute to reversal of inflammatory-induced spinal sensitization as indicated by the unique selectivity profile of the GABAA receptor allosteric modulator NS16085

被引:29
作者
Garcia de Lucas, A. [1 ]
Ahring, P. K. [2 ,3 ]
Larsen, J. S. [2 ]
Rivera-Arconada, I. [1 ]
Lopez-Garcia, J. A. [1 ]
Mirza, N. R. [2 ]
Munro, G. [4 ]
机构
[1] Univ Alcala, Dept Physiol, Madrid, Spain
[2] Saniona AB, DK-2750 Ballerup, Denmark
[3] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia
[4] NeuroSearch AS, Dept Pharmacol, DK-2750 Ballerup, Denmark
关键词
Analgesia; Central sensitization; Hyperalgesia; Pain; Spinal inhibition; Wind-up; DORSAL-HORN; PATHOLOGICAL PAIN; RAT MODELS; IN-VITRO; AGONIST; DIAZEPAM; LORAZEPAM; SUBTYPES; CORD; HYPERSENSITIVITY;
D O I
10.1016/j.bcp.2014.12.010
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
GABA(A) receptor positive allosteric modulators (PAMs) mediate robust analgesia in animal models of pathological pain. Restoration of diminished spinal GABA(A)-alpha 2 and -alpha 3 subunit-containing receptor function is a principal contributor to this analgesia, albeit involvement of GABA(A)-alpha 5-receptors has not been excluded. Thus, we compared NS11394 and TPA023 (PAMs with selectivity/efficacy at GABA(A)-alpha 2/ alpha 3/alpha 5 receptors) with TP003 (a reportedly GABA(A)-alpha 3 selective PAM) against spinal sensitization. However, in-house electrophysiology studies designed to confirm the selectivity of TPA023 and TP003 for human GABA(A) receptors did not corroborate published data, with TP003 displaying considerable GABA(A)-alpha 5 receptor efficacy. Therefore, we identified a novel PAM, NS16085, which possesses negligible efficacy at GABA(A)-alpha 5 receptors, but with GABA(A)-alpha 2/alpha 3 efficacy equivalent to NS11394. At the GABA(A)-alpha 1 receptor the compound gives low level of negative modulation further separating it from the other compounds. Rat pups with carrageenan-induced hindpaw inflammatory hyperalgesia were used to make ex vivo spinal dorsal root-evoked ventral root recordings. Some spontaneous activity and large numbers of spikes to repetitive stimulation of dorsal roots at C-fibre intensity, indicative of wind-up and sensitization were observed. Equimolar concentrations of NS11394, TP003 and NS16085 all attenuated wind-up to a similar degree; TPA023 was clearly less effective. In adult rats, NS16085 (3-30 mg/kg, p.o.) dose-dependently reduced formalin-induced hindpaw flinching with efficacy comparable to NS11394. Thus, potentiation of GABA(A)-alpha 2 and-alpha 3 receptors is sufficient to depress spinal sensitization and mediate analgesia after inflammatory injury. Positive modulation at GABA(A)-alpha 5-receptors is apparently dispensable for this process, an important consideration given the role of this receptor subtype in cognitive function. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:370 / 379
页数:10
相关论文
共 45 条
[1]   Benzodiazepine Binding Site Occupancy by the Novel GABAA Receptor Subtype-Selective Drug 7-(1,1-Dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine (TPA023) in Rats, Primates, and Humans [J].
Atack, John R. ;
Wong, Dean F. ;
Fryer, Tim D. ;
Ryan, Christine ;
Sanabria, Sandra ;
Zhou, Yun ;
Dannals, Robert F. ;
Eng, Wai-si ;
Gibson, Raymond E. ;
Burns, H. Donald ;
Vega, Jose M. ;
Vessy, Laura ;
Scott-Stevens, Paul ;
Beech, John S. ;
Baron, Jean-Claude ;
Sohal, Bindi ;
Schrag, Michael L. ;
Aigbirhio, Franklin I. ;
McKernan, Ruth M. ;
Hargreaves, Richard J. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 332 (01) :17-25
[2]   TPA023 [7-(1,1-dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine], an agonist selective for α2-and α3-containing GABAA receptors, is a nonsedating anxiolytic in rodents and primates [J].
Atack, JR ;
Wafford, KA ;
Tye, SJ ;
Cook, SM ;
Sohal, B ;
Pike, A ;
Sur, C ;
Melillo, D ;
Bristow, L ;
Bromidge, F ;
Ragan, I ;
Kerby, J ;
Street, L ;
Carling, R ;
Castro, JL ;
Whiting, P ;
Dawson, GR ;
McKernan, RM .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 316 (01) :410-422
[3]   CONTRIBUTION OF CENTRAL NEUROPLASTICITY TO PATHOLOGICAL PAIN - REVIEW OF CLINICAL AND EXPERIMENTAL-EVIDENCE [J].
CODERRE, TJ ;
KATZ, J ;
VACCARINO, AL ;
MELZACK, R .
PAIN, 1993, 52 (03) :259-285
[4]   Pharmacodynamic and pharmacokinetic effects of MK-0343, a GABAA α2,3 subtype selective agonist, compared to lorazepam and placebo in healthy male volunteers [J].
de Haas, S. L. ;
de Visser, S. J. ;
van der Post, J. P. ;
Schoemaker, R. C. ;
van Dyck, K. ;
Murphy, M. G. ;
de Smet, M. ;
Vessey, L. K. ;
Ramakrishnan, R. ;
Xue, L. ;
Cohen, A. F. ;
van Gerven, J. M. A. .
JOURNAL OF PSYCHOPHARMACOLOGY, 2008, 22 (01) :24-32
[5]   The pharmacokinetic and pharmacodynamic effects of SL65.1498, a GABA-A α2,3 selective agonist, in comparison with lorazepam in healthy volunteers [J].
de Haas, S. L. ;
Franson, K. L. ;
Schmitt, J. A. J. ;
Cohen, A. F. ;
Fau, J. B. ;
Dubruc, C. ;
van Gerven, J. M. A. .
JOURNAL OF PSYCHOPHARMACOLOGY, 2009, 23 (06) :625-632
[6]   Pharmacodynamic and pharmacokinetic effects of TPA023, a GABAAα2,3 subtype-selective agonist, compared to lorazepam and placebo in healthy volunteers [J].
de Hass, S. L. ;
de Visser, S. J. ;
van der Post, J. P. ;
de Smet, M. ;
Schoemaker, R. C. ;
Rijnbeek, B. ;
Cohen, A. F. ;
Vega, J. M. ;
Agrawal, N. G. B. ;
Goel, T. V. ;
Simpson, R. C. ;
Pearson, L. K. ;
Li, S. ;
Hesney, M. ;
Murphy, M. G. ;
van Gerven, J. M. A. .
JOURNAL OF PSYCHOPHARMACOLOGY, 2007, 21 (04) :374-383
[7]   HZ166, a novel GABAA receptor subtype-selective benzodiazepine site ligand, is antihyperalgesic in mouse models of inflammatory and neuropathic pain [J].
Di Lio, Alessandra ;
Benke, Dietmar ;
Besson, Marie ;
Desmeules, Jules ;
Daali, Youssef ;
Wang, Zhi-jian ;
Edwankar, Rahul ;
Cook, James M. ;
Zeilhofer, Hanns Ulrich .
NEUROPHARMACOLOGY, 2011, 60 (04) :626-632
[8]   Evidence for a significant role of α3-containing GABAA receptors in mediating the anxiolytic effects of benzodiazepines [J].
Dias, R ;
Sheppard, WFA ;
Fradley, RL ;
Garrett, EM ;
Stanley, JL ;
Tye, SJ ;
Goodacre, S ;
Lincoln, RJ ;
Cook, SM ;
Conley, R ;
Hallett, D ;
Humphries, AC ;
Thompson, SA ;
Wafford, KA ;
Street, LJ ;
Castro, JL ;
Whiting, PJ ;
Rosahl, TW ;
Atack, JR ;
McKernan, RM ;
Dawson, GR ;
Reynolds, DS .
JOURNAL OF NEUROSCIENCE, 2005, 25 (46) :10682-10688
[9]   EVIDENCE FOR A ROLE OF THE NMDA RECEPTOR IN THE FREQUENCY-DEPENDENT POTENTIATION OF DEEP RAT DORSAL HORN NOCICEPTIVE NEURONS FOLLOWING C-FIBER STIMULATION [J].
DICKENSON, AH ;
SULLIVAN, AF .
NEUROPHARMACOLOGY, 1987, 26 (08) :1235-1238
[10]   Positive allosteric modulation of GABA-A receptors reduces capsaicin-induced primary and secondary hypersensitivity in rats [J].
Hansen, Rikke R. ;
Erichsen, Helle K. ;
Brown, David T. ;
Mirza, Naheed R. ;
Munro, Gordon .
NEUROPHARMACOLOGY, 2012, 63 (08) :1360-1367